Turn Therapeutics Inc.
TTRX
$13.83
$1.179.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.61M | 974.50K | 496.90K | -- | -- |
| Gross Profit | -1.61M | -974.50K | -496.90K | -- | -- |
| SG&A Expenses | 6.20M | 6.35M | 5.59M | 3.75M | 2.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.59M | 7.69M | 6.36M | 3.99M | 2.75M |
| Operating Income | -8.59M | -7.69M | -6.36M | -3.99M | -2.75M |
| Income Before Tax | -8.45M | -3.84M | -3.19M | -3.80M | -2.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.45 | -3.84 | -3.19 | -3.80 | -2.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.45M | -3.84M | -3.19M | -3.80M | -2.56M |
| EBIT | -8.59M | -7.69M | -6.36M | -3.99M | -2.75M |
| EBITDA | -8.54M | -7.64M | -6.30M | -3.94M | -2.70M |
| EPS Basic | -0.29 | -0.14 | -0.12 | -0.14 | -0.09 |
| Normalized Basic EPS | -0.18 | -0.09 | -0.07 | -0.09 | -0.06 |
| EPS Diluted | -0.29 | -0.14 | -0.12 | -0.14 | -0.09 |
| Normalized Diluted EPS | -0.18 | -0.09 | -0.07 | -0.09 | -0.06 |
| Average Basic Shares Outstanding | 115.67M | 113.37M | 110.85M | 109.36M | 108.03M |
| Average Diluted Shares Outstanding | 115.67M | 113.37M | 110.85M | 109.36M | 108.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |